マニー reported ordinary profit of ¥10,554 million for the fiscal year ended August 2026, a 27.6% increase in profit and 2.1% above the IFIS consensus. It also forecast ordinary profit of ¥10,900 million for the fiscal year ending August 2027, indicating further profit growth year on year.
マニー reported ordinary profit of ¥10,554 million for the fiscal year ended August 2026, representing a 27.6% increase from the previous fiscal year. This was 2.1% above the IFIS consensus of ¥10,338 million.
In its results forecast for the fiscal year ending August 2027, announced the same day, the company forecast ordinary profit of ¥10,900 million. This is 1.5% above the IFIS consensus and indicates an outlook for higher profit.
Interim ordinary profit is forecast at ¥5,000 million. Growth factors in combination with the full-year outlook are attracting attention.
Major medical-device companies are cited as related stocks, in a situation said to be drawing investor attention.